BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25628470)

  • 1. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.
    Geskin LJ; Viragova S; Stolz DB; Fuschiotti P
    Blood; 2015 Apr; 125(18):2798-805. PubMed ID: 25628470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma.
    Huang Y; Su MW; Jiang X; Zhou Y
    Blood; 2015 Feb; 125(9):1435-43. PubMed ID: 25548321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.
    Curiel-Lewandrowski C; Yamasaki H; Si CP; Jin X; Zhang Y; Richmond J; Tuzova M; Wilson K; Sullivan B; Jones D; Ryzhenko N; Little F; Kupper TS; Center DM; Cruikshank WW
    J Clin Invest; 2011 Dec; 121(12):4838-49. PubMed ID: 22080865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
    Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
    J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Granulysin and FOXP3 in Cutaneous T Cell Lymphoma and Sézary Syndrome.
    Shareef MM; Elgarhy LH; Wasfy Rel-S
    Asian Pac J Cancer Prev; 2015; 16(13):5359-64. PubMed ID: 26225678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
    Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X
    Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
    da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
    Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 Regulates IL-4 Expression in TOX
    Huanosta-Murillo E; Alcántara-Hernández M; Hernández-Rico B; Victoria-Acosta G; Miranda-Cruz P; Domínguez-Gómez MA; Jurado-Santacruz F; Patiño-López G; Pérez-Koldenkova V; Palma-Guzmán A; Licona-Limón P; Fuentes-Pananá EM; Lemini-López A; Bonifaz LC
    Front Immunol; 2021; 12():668369. PubMed ID: 34220814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
    Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3.
    Nielsen M; Nissen MH; Gerwien J; Zocca MB; Rasmussen HM; Nakajima K; Röpke C; Geisler C; Kaltoft K; Ødum N
    Blood; 2002 Feb; 99(3):973-7. PubMed ID: 11807001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Rich B; Dowgiert R; Hirahara K; Hurwitz D; Shibata M; Mirchandani N; Jones DA; Goddard DS; Eapen S; Mizutani H; Kupper TS
    Blood; 2006 Mar; 107(6):2440-5. PubMed ID: 16322477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
    Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
    Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma.
    Abraham RM; Zhang Q; Odum N; Wasik MA
    Cancer Biol Ther; 2011 Dec; 12(12):1019-22. PubMed ID: 22236880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47.
    Kamijo H; Miyagaki T; Takahashi-Shishido N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S
    Leukemia; 2020 Mar; 34(3):845-856. PubMed ID: 31712778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
    Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.
    Oka T; Sugaya M; Takahashi N; Nakajima R; Otobe S; Kabasawa M; Suga H; Miyagaki T; Asano Y; Sato S
    Acta Derm Venereol; 2017 Nov; 97(10):1172-1177. PubMed ID: 28597022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.